GlassScriptPhysician profile
Jacqueline Baker
NPI 1659708022
$1,858.76
in general payments reported to CMS, 2019-2025
15 companies · $393 in 2025
The $393 reported for 2025 was more than what 75% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $87.51 · 2022: $265 · 2023: $677 · 2024: $436 · 2025: $393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,506.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $348.81 | 2023-2024 | |
| Gilead Sciences, INC. | $183.29 | 2023-2025 | Epclusa, Vemlidy |
| Abbott Laboratories | $180.15 | 2023 | Freestyle Libre 3 |
| Madrigal Pharmaceuticals | $139.99 | 2025 | Rezdiffra |
| Lucid Diagnostics INC. | $137.55 | 2024 | |
| Acadia Pharmaceuticals INC | $120.99 | 2024 | Daybue |
| Inspire Medical Systems, INC. | $94.69 | 2023 | Inspire |
| Ultragenyx Pharmaceutical INC. | $93.62 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $87.51 | 2021 | |
| Scynexis, INC. | $85.96 | 2022 | |
| Sk Life Science, INC. | $85.35 | 2022 | |
| Abiomed | $82.00 | 2025 | |
| Jazz Pharmaceuticals INC. | $77.88 | 2025 | |
| Abbvie INC. | $77.64 | 2024 | |
| Coloplast Corp | $63.33 | 2023 | Altis, Titan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.